1 INDICATIONS AND USAGE Solifenacin succinate is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate is a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )
ScieGen Pharmaceuticals, Inc.
16 HOW SUPPLIED/STORAGE AND HANDLING
SOLIFENACIN SUCCINATE tablets, 5 mg, are light yellow, round, film coated tablets debossed with 'SG' on one side and '427' on other side. They are supplied as follows: NDC 50228-427-30 bottles of 30 NDC 50228-427-90 bottles of 90 NDC 50228-427-05 bottles of 500
SOLIFENACIN SUCCINATE tablets, 10 mg, are light pink, round, film coated tablets debossed with 'SG' on one side and '428' on other side. They are supplied as follows: NDC 50228-428-30 bottles of 30 NDC 50228-428-90 bottles of 90 NDC 50228-428-05 bottles of 500 Store at 25Â°C (77Â°F) with excursions permitted from 15Â°C to 30Â°C (59Â°F to 86Â°F). [See USP Controlled Room Temperature].
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site